Potential use of plasma focus radiation sources in superficial cancer therapy by Poh, H. S. et al.
Potential use of plasma focus radiation sources in superficial cancer therapy
H. S. Poh1, M. C. Lee1, S. S. Yap2, S. Y. Teow3 , D. A. Bradley4,5, and S. L. Yap1*
1Plasma Technology Research Centre, Department of Physics, Faculty of Science, University of Malaya, 50603 Kuala Lumpur, Malaysia
2Faculty of Engineering, Multimedia University, 63000 Cyberjaya, Selangor, Malaysia
3Department of Medical Sciences, School of Healthcare and Medical Sciences, Sunway University, Malaysia
4Centre for Biomedical Physics, School of Healthcare and Medical Sciences, Sunway University, Malaysia
5Department of Physics, University of Surrey, Guildford, Surrey, GU2 7XH, United Kingdom
*E-mail: yapsl@um.edu.my
Received October 31, 2019; revised February 18, 2020; accepted March 3, 2020; published online April 1, 2020
The new multidisciplinary field of plasma medicine combines plasma physics, electrical engineering, life sciences and clinical medicine.
Bekeschus et al. [Plasma Processes Polym. 16, 1800033 (2019)]. Here we explore potential uses in medicine, most particularly cancer therapy,
the plasma source being brought out of the field of industrial applications into the life sciences, the focus being on superficial cancer radiotherapy
strategies. Existing radiotherapy practices for such cancers rely on the use of rather large facilities, most popularly the electron linear accelerator
and X-ray tube-based devices. Conversely, a compact plasma radiation source can be housed in a relatively small space, there being considerable
promise for such devices to produce the fluence requirements of radiotherapy for treatment of skin cancers. The present study of feasibility
investigates the plasma focus device, with the emission produced by a single discharge shown to generate an X-ray dose of few tens of mGy. The
X-ray dose is the integration of emission in the discharge durations of less than a !s, it is therefore possible using these devices to build up
fractional irradiation dose through repetitive operation of the discharge system. © 2020 The Japan Society of Applied Physics
1. Introduction
Radiation oncology together with surgery and chemotherapy,
represents the three most prominent approaches in the
treatment of cancer, with as an instance nearly two-thirds
of cancer patients in the United States receiving radiotherapy.
It is also the most effective form of palliation when a cure is
no longer possible. In treating cancer, it is important for
optimum outcome to effectively provide a near homogenous
dose to the target volume while also seeking to mitigate dose
to the surrounding normal tissue. Although in most cases the
ef!cacy of radiation is not sensitive to cell type, nevertheless
the greatest impact is to cells that are in the process of
replication during irradiation as well as those that are more
richly oxygenated. In these several respects, radiotherapy
needs to be planned carefully with respect to dose in order to
ensure optimal ef!ciency for tumourcidal outcome with
minimal side effects.
Dose delivery and its control is multidisciplinary, invol-
ving complex radiation sources, engineered movement,
location and collimation and dosimetry, involving X- and
gamma-rays, charged particles and neutrons. It now repre-
sents a sophisticated endeavor that !rst began with the
tentative steps of an American physician who used X-rays
in an effort to treat cancer.1) Three main groups of X-ray
sources have been developed: (i) tube X-ray machines with
solid target sources;2–4) (ii) linear accelerators (hereafter
referred to as the LINAC)5) and; (iii) synchrotron radiation
sources,6) albeit with the latter !rmly remaining a research
tool.
In radiation medicine the demand for radiation facilities
has continued to increase, with as an instance the number of
new cancer patients in the United States reaching some 1.6
million in 2014.7) Indeed, cancer remains the second most
common cause of death in the US, accounting for nearly 1 of
every 4 deaths. A report summarizing the X-ray facilities
used in medicine showed that in 2008 there were a total of
3300 facilities in developing countries whereas at the time the
demand was for 5000 facilities.8) An innovative plasma
radiation source could lessen the burden of providing for at
least some of the cancer treatments through radiotherapy,
!nding a particular niche in treatment of super!cial tumors.9)
Both laser-produced plasma sources and discharge-pro-
duced plasma sources can be operated to obtain X-ray
production. Laser-produced plasma typically requires a high
intensity laser beam to focus and heat a solid target and turn
the material into plasma,10) while discharge-produced plasma
uses high voltage to produce plasma via the pinch me-
chanism. The advantage of pinch type plasma devices such as
the plasma focus over the laser-produced plasma is the
greater conversion ef!ciency of input electrical energy into
X-ray photo-energy. The ef!ciency of the plasma radiation
source is also greater compared to the tube X-ray machine
based on use of a solid target, with a wall-plug ef!ciency of
as high as 25% having been reported in use of the plasma
focus to produce X-rays.11) This can be compared to
conventional electron impact sources with ef!ciency of only
0.1%.12) Furthermore, the plasma focus is a very compact,
cost effective and easy to maintain technique. The purpose of
investigating the feasibility of the plasma focus device as a
potential X-ray source for applications in radiation medicine
is based on the following speci!c characteristics: the X-ray is
produced in a pulse which contains simultaneously the soft
and hard X-ray component. The hard X-ray component with
energy of 0.01–1MeV has a very !ne temporal structure with
a typical duration of about 10!13 s. Conversely, for the small
and medium plasma focus devices, the soft X-ray pulse lasts
for 1–10 ns. An X-ray yield of between 0.1 J/shot up to 30 kJ/
shot has been reported depending on the energy stored in the
capacitor bank.13) Moreover, the size of the X-ray source can
be down to 3 !m and as such could offer a high spatial
resolution.14) Due to the pulsed nature of the emission and
high power, imaging with lower dose could also be made
possible.14) Gribkov et al.13) has reported that the multiple
pulsed radiation emission from the plasma focus has success-
fully decreased the required dose for the production of
radiation effects by four orders of magnitude, leading to
important medical applications. In this work, we investigated
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